1. Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy
- Author
-
Xi, Chenxiang, Yan, Zihui, Bai, Dandan, Zhang, Yalin, Wang, Beiying, Han, Xiaoxiao, Wu, Li, Shi, Xiaohui, Hu, Zhiyi, Tang, Ming, Su, Zhongqu, Liu, Yingdong, Liu, Binya, Yin, Jiqing, Wang, Hong, Li, Xiaocui, Zhang, Yanping, Gao, Shaorong, and Liu, Wenqiang
- Abstract
The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a threat to pregnant women. However, the impact of early pregnancy SARS-CoV-2 infection on the maternal-fetal interface remains poorly understood. Here, we present a comprehensive analysis of single-cell transcriptomics and metabolomics in placental samples infected with SARS-CoV-2 during early pregnancy. Compared to control placentas, SARS-CoV-2 infection elicited immune responses at the maternal-fetal interface and induced metabolic alterations in amino acid and phospholipid profiles during the initial weeks post-infection. However, subsequent immune cell activation and heightened immune tolerance in trophoblast cells established a novel dynamic equilibrium that mitigated the impact on the maternal-fetal interface. Notably, the immune response and metabolic alterations at the maternal-fetal interface exhibited a gradual decline during the second trimester. Our study underscores the adaptive immune tolerance mechanisms and establishment of immunological balance during the first two trimesters following maternal SARS-CoV-2 infection.
- Published
- 2024
- Full Text
- View/download PDF